Sangamo Therapeutics
SGMO
#10434
Rank
ยฃ22.95 M
Marketcap
ยฃ0.05540
Share price
0.00%
Change (1 day)
-87.59%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -ยฃ82.12 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ34.55 Million. In 2025 the company made an earning of -ยฃ80.86 Million a decrease over its 2024 earnings that were of -ยฃ73.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ82.12 Million1.55%
2025 -ยฃ80.86 Million9.71%
2024 -ยฃ73.71 Million-17.27%
2023 -ยฃ89.09 Million-40.88%
2022 -ยฃ0.16 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ97 Million23.17%
2019 -ยฃ78.75 Million36.33%
2018 -ยฃ57.76 Million36.89%
2017 -ยฃ42.2 Million-22.32%
2016 -ยฃ54.33 Million54.86%
2015 -ยฃ35.08 Million75.62%
2014 -ยฃ19.98 Million0.13%
2013 -ยฃ19.95 Million
2011 -ยฃ26.82 Million43.66%
2010 -ยฃ18.67 Million28.52%
2009 -ยฃ14.53 Million-23.55%
2008 -ยฃ19 Million2.45%
2007 -ยฃ18.55 Million19.5%
2006 -ยฃ15.52 Million50.78%
2005 -ยฃ10.3 Million75%
2004 -ยฃ5.89 Million-33.25%
2003 -ยฃ8.82 Million-62.27%
2002 -ยฃ23.36 Million102.82%
2001 -ยฃ11.52 Million23.21%
2000 -ยฃ9.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.44 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.80 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.21 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ1.9 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ8.03 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.84 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.65 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.28 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA